Status of Baricitinib, Bezisterim and WASF3 research after recent funding cuts

I don't have any knowledge of The DOD Bezisterim trial or Paul Hwangs WASF3 work at this time, but as of 3/5/25 Baricitinib trial was still on and moving forward.

Obviously a lot of this is fluid

I don't recall Paul Hwang receiving grants to work on WASF3 in ME/CFS, so presumably it's all up to how much time off from his other work and how much of his other resources he uses for this.
 
Back
Top Bottom